Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction [corrected] [published erratum appears in CRIT CARE MED 2008 Oct;36(10):2966].
Saved in:
| Title: | Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction [corrected] [published erratum appears in CRIT CARE MED 2008 Oct;36(10):2966]. |
|---|---|
| Authors: | Fuhrmann JT (AUTHOR), Schmeisser A (AUTHOR), Schulze MR (AUTHOR), Wunderlich C (AUTHOR), Schoen SP (AUTHOR), Rauwolf T (AUTHOR), Weinbrenner C (AUTHOR), Strasser RH (AUTHOR) |
| Source: | Critical Care Medicine. Aug2008, Vol. 36 Issue 8, p2257-2266. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
